189 related articles for article (PubMed ID: 30179848)
1. Current understanding and future directions in the application of TIMP-2 and IGFBP7 in AKI clinical practice.
Fan W; Ankawi G; Zhang J; Digvijay K; Giavarina D; Yin Y; Ronco C
Clin Chem Lab Med; 2019 Apr; 57(5):567-576. PubMed ID: 30179848
[TBL] [Abstract][Full Text] [Related]
2. Biomarker Rule-in or Rule-out in Patients With Acute Diseases for Validation of Acute Kidney Injury in the Emergency Department (BRAVA): A Multicenter Study Evaluating Urinary TIMP-2/IGFBP7.
Yang HS; Hur M; Lee KR; Kim H; Kim HY; Kim JW; Chua MT; Kuan WS; Chua HR; Kitiyakara C; Phattharapornjaroen P; Chittamma A; Werayachankul T; Anandh U; Herath S; Endre Z; Horvath AR; Antonini P; Di Somma S;
Ann Lab Med; 2022 Mar; 42(2):178-187. PubMed ID: 34635611
[TBL] [Abstract][Full Text] [Related]
3. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury.
Kashani K; Al-Khafaji A; Ardiles T; Artigas A; Bagshaw SM; Bell M; Bihorac A; Birkhahn R; Cely CM; Chawla LS; Davison DL; Feldkamp T; Forni LG; Gong MN; Gunnerson KJ; Haase M; Hackett J; Honore PM; Hoste EA; Joannes-Boyau O; Joannidis M; Kim P; Koyner JL; Laskowitz DT; Lissauer ME; Marx G; McCullough PA; Mullaney S; Ostermann M; Rimmelé T; Shapiro NI; Shaw AD; Shi J; Sprague AM; Vincent JL; Vinsonneau C; Wagner L; Walker MG; Wilkerson RG; Zacharowski K; Kellum JA
Crit Care; 2013 Feb; 17(1):R25. PubMed ID: 23388612
[TBL] [Abstract][Full Text] [Related]
4. Tissue Inhibitor Metalloproteinase-2·IGF-Binding Protein 7 for the Prediction of Acute Kidney Injury following Cardiac Surgery.
Xie Y; Guo Q; Yang B; Xie P; Zhang J; Lu W; Ronco C; Jiang G
Cardiorenal Med; 2024; 14(1):251-260. PubMed ID: 38588650
[TBL] [Abstract][Full Text] [Related]
5. Predictive performance of two types of urinary biomarkers for renal non-recovery in sepsis-associated acute kidney injury: a prospective observational study.
Licheng ; Jia H; Jiang Y; Li W
BMC Nephrol; 2024 May; 25(1):153. PubMed ID: 38702662
[TBL] [Abstract][Full Text] [Related]
6. Biomarker-Guided Risk Assessment for Acute Kidney Injury: Time for Clinical Implementation?
Albert C; Haase M; Albert A; Zapf A; Braun-Dullaeus RC; Haase-Fielitz A
Ann Lab Med; 2021 Jan; 41(1):1-15. PubMed ID: 32829575
[TBL] [Abstract][Full Text] [Related]
7. Utility of Biomarkers for Sepsis-Associated Acute Kidney Injury Staging.
Molinari L; Del Rio-Pertuz G; Smith A; Landsittel DP; Singbartl K; Palevsky PM; Chawla LS; Huang DT; Yealy DM; Angus DC; Kellum JA;
JAMA Netw Open; 2022 May; 5(5):e2212709. PubMed ID: 35583867
[TBL] [Abstract][Full Text] [Related]
8. Impact of Isolyte Versus 0.9% Saline on Postoperative Event of Acute Kidney Injury Assayed by Urinary [TIMP-2] × [IGFBP7] in Patients Undergoing Cardiac Surgery.
Lee NM; Deriy L; Petersen TR; Shah VO; Hutchens MP; Gerstein NS
J Cardiothorac Vasc Anesth; 2019 Feb; 33(2):348-356. PubMed ID: 30181085
[TBL] [Abstract][Full Text] [Related]
9. Real-World Use of AKI Biomarkers: A Quality Improvement Project Using Urinary Tissue Inhibitor Metalloprotease-2 and Insulin-Like Growth Factor Binding Protein 7 ([TIMP-2]*[IGFBP7]).
La AM; Gunning S; Trevino SA; Kunczt A; Forni LG; Swamy V; Zarbock A; Groboske S; Leung EKY; Yeo KJ; Koyner JL
Am J Nephrol; 2023; 54(7-8):281-290. PubMed ID: 37356428
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of urinary tissue inhibitor of metalloproteinase-2 and insulin-like growth factor binding protein 7 for acute kidney injury: a meta-analysis.
Jia HM; Huang LF; Zheng Y; Li WX
Crit Care; 2017 Mar; 21(1):77. PubMed ID: 28340605
[TBL] [Abstract][Full Text] [Related]
11. Routine Adoption of Urinary [IGFBP7]∙[TIMP-2] to Assess Acute Kidney Injury at Any Stage 12 hours After Intensive Care Unit Admission: a Prospective Cohort Study.
Ferrari F; Romero-González G; Topete LR; Senzolo M; Lorenzin A; Husain-Syed F; Puci MV; Ferraro OE; Muraro E; Serrano-Soto M; Triviño AM; Castro AC; Xie Y; Yang B; De Cal M; Corradi V; Brendolan A; Scarpa M; Carta MR; Giavarina D; Bonato R; Ronco C
Sci Rep; 2019 Nov; 9(1):16484. PubMed ID: 31712687
[TBL] [Abstract][Full Text] [Related]
12. The Role of Cell Cycle Arrest Biomarkers for Predicting Acute Kidney Injury in Critically Ill COVID-19 Patients: A Multicenter, Observational Study.
Weiss R; von Groote T; Ostermann M; Lumlertgul N; Weerapolchai K; Garcia MIM; Cano JMM; Del Corral BD; Broch-Porcar MJ; Perez Carrasco M; De la Vega Sanchez A; Sousa E; Catarino A; Roig AJB; Martinez de Irujo JB; de Rosa S; de la Peña MG; Tomasa T; Brivio M; De Molina FJG; Gerss J; Kellum JA; Wempe C; Leidereiter A; Meersch M; Zarbock A
Crit Care Med; 2023 Aug; 51(8):992-1000. PubMed ID: 36975308
[TBL] [Abstract][Full Text] [Related]
13. Association between the levels of urinary cell cycle biomarkers and non-recovery of renal function among critically ill geriatric patients with acute kidney injury.
Cheng L; Jia HM; Zheng X; Jiang YJ; Xin X; Li WX
Ren Fail; 2024 Dec; 46(1):2304099. PubMed ID: 38390828
[TBL] [Abstract][Full Text] [Related]
14. Urinary cell cycle biomarkers for the prediction of renal non-recovery in patients with septic acute kidney injury: a prospective study.
Cheng L; Jia HM; Zheng X; Jiang YJ; Zhang TE; Li WX
Clin Exp Nephrol; 2023 Dec; 27(12):1051-1059. PubMed ID: 37656396
[TBL] [Abstract][Full Text] [Related]
15. Acute kidney injury in critical COVID-19 patients: usefulness of urinary biomarkers and kidney proximal tubulopathy.
Larcher R; Bargnoux AS; Badiou S; Besnard N; Brunot V; Daubin D; Platon L; Benomar R; Amalric M; Dupuy AM; Klouche K; Cristol JP
Ren Fail; 2023; 45(2):2292152. PubMed ID: 38078385
[TBL] [Abstract][Full Text] [Related]
16. The role of biomarkers in early identification of acute kidney injury among non-critically ill patients.
Safadi S; Hommos MS; Thongprayoon C; Giesen CD; Bernaba M; Kashani KB; Lieske JC
J Nephrol; 2024 Jun; ():. PubMed ID: 38837000
[TBL] [Abstract][Full Text] [Related]
17. Urinary beta-2 microglobulin increases whereas TIMP-2 and IGFBP7 decline after unilateral nephrectomy in healthy kidney donors.
de Rooij ENM; Hoogeveen EK; Romijn FPHTM; van der Kooy SW; Veighey KV; Dekker FW; van Kooten C; Cobbaert CM; de Fijter JW
Sci Rep; 2024 Jun; 14(1):12901. PubMed ID: 38839764
[TBL] [Abstract][Full Text] [Related]
18. Urinary Biomarkers for Cell Cycle Arrest TIMP-2 and IGFBP7 for Prediction of Graft Function Recovery after Kidney Transplantation.
Gäckler A; Ertasoglu O; Rohn H; Friebus-Kardash J; Ickerott PC; Witzke O; Kribben A; Vogt B; Dahdal S; Arampatzis S; Eisenberger U
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673754
[TBL] [Abstract][Full Text] [Related]
19. Mechanism and clinical role of TIMP-2 and IGFBP-7 in cardiac surgery-associated acute kidney injury: A review.
Leng J; Li L; Tu H; Luo Y; Cao Z; Zhou K; Rizvi SMM; Tie H; Jiang Y
Medicine (Baltimore); 2024 May; 103(21):e38124. PubMed ID: 38788006
[TBL] [Abstract][Full Text] [Related]
20. The combination of kidney function variables with cell cycle arrest biomarkers identifies distinct subphenotypes of sepsis-associated acute kidney injury: a
Titeca-Beauport D; Diouf M; Daubin D; Vong LV; Belliard G; Bruel C; Zerbib Y; Vinsonneau C; Klouche K; Maizel J
Ren Fail; 2024 Dec; 46(1):2325640. PubMed ID: 38445412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
